Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties, according to research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024. Fragile X syndrome and Phelan-McDermid syndrome are two genetic conditions that cause a variety of neurodevelopmental difficulties throughout life. Both conditions have a high incidence of autism spectrum disorder, including speech delay, social difficulties and repetitive behavior. The research was presented by Dr. Ilse Gantois from McGill University, Read More